Clinical Trials on Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Finland
Total 7 results
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Taiwan, Italy, Poland, Peru, Canada, Denmark, Germany, Slovakia, Spain, United Kingdom, New Zealand, China, Greece, Hong Kong, Russian Federation, Austria, Netherlands, Czech Republic, France, India, Ukraine, Tunisia, F... and more
-
Principia Biopharma, a Sanofi CompanyActive, not recruitingImmune Thrombocytopenia | Immune Thrombocytopenic PurpuraUnited States, Australia, Bulgaria, Canada, Czechia, Netherlands, Norway, United Kingdom
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
OctapharmaActive, not recruitingChronic Immune ThrombocytopeniaUnited States
-
Sobi, Inc.Active, not recruitingImmune ThrombocytopeniaUnited States, France, Germany, Hungary, Poland, Russian Federation, Turkey, Ukraine, United Kingdom
-
Baylor College of MedicineBoston Children's Hospital; University of California, San FranciscoActive, not recruitingImmune ThrombocytopeniaUnited States
-
Boston Children's HospitalTerrana ITP Research FundCompletedImmune ThrombocytopeniaUnited States, Canada